rs587777688

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong

The NM_005726.6(TSFM):​c.944G>A​(p.Cys315Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 1,452,644 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

TSFM
NM_005726.6 missense

Scores

5
11
2

Clinical Significance

Likely pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 7.70

Publications

4 publications found
Variant links:
Genes affected
TSFM (HGNC:12367): (Ts translation elongation factor, mitochondrial) This gene encodes a mitochondrial translation elongation factor. The encoded protein is an enzyme that catalyzes the exchange of guanine nucleotides on the translation elongation factor Tu during the elongation step of mitchondrial protein translation. Mutations in this gene are associated with combined oxidative phosphorylation deficiency-3 syndrome. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Mar 2010]
TSFM Gene-Disease associations (from GenCC):
  • fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-57796549-G-A is Pathogenic according to our data. Variant chr12-57796549-G-A is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 155719.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005726.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSFM
NM_005726.6
MANE Select
c.944G>Ap.Cys315Tyr
missense
Exon 6 of 6NP_005717.3
TSFM
NM_001172696.2
c.1007G>Ap.Cys336Tyr
missense
Exon 7 of 7NP_001166167.1
TSFM
NM_001172695.2
c.*352G>A
3_prime_UTR
Exon 5 of 5NP_001166166.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSFM
ENST00000652027.2
MANE Select
c.944G>Ap.Cys315Tyr
missense
Exon 6 of 6ENSP00000499171.2
TSFM
ENST00000323833.12
TSL:1
c.1007G>Ap.Cys336Tyr
missense
Exon 7 of 7ENSP00000313877.8
TSFM
ENST00000543727.5
TSL:1
c.571+3476G>A
intron
N/AENSP00000439342.1

Frequencies

GnomAD3 genomes
AF:
0.0000328
AC:
5
AN:
152224
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000600
AC:
1
AN:
166578
AF XY:
0.0000114
show subpopulations
Gnomad AFR exome
AF:
0.0000685
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000108
AC:
14
AN:
1300420
Hom.:
0
Cov.:
31
AF XY:
0.0000111
AC XY:
7
AN XY:
631626
show subpopulations
African (AFR)
AF:
0.0000340
AC:
1
AN:
29382
American (AMR)
AF:
0.00
AC:
0
AN:
26214
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18516
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37532
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54194
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5098
European-Non Finnish (NFE)
AF:
0.0000107
AC:
11
AN:
1029606
Other (OTH)
AF:
0.0000376
AC:
2
AN:
53254
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000328
AC:
5
AN:
152224
Hom.:
0
Cov.:
32
AF XY:
0.0000538
AC XY:
4
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41470
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68038
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000267
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.00000849
AC:
1

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 Pathogenic:3
May 31, 2021
Revvity Omics, Revvity
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 23, 2023
Baylor Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 19, 2014
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

not provided Pathogenic:2
May 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 336 of the TSFM protein (p.Cys336Tyr). This variant is present in population databases (rs587777688, gnomAD 0.004%). This missense change has been observed in individual(s) with clinical features of Leigh syndrome (PMID: 25037205). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as C315Y. ClinVar contains an entry for this variant (Variation ID: 155719). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TSFM protein function with a positive predictive value of 80%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

Sep 01, 2016
CeGaT Center for Human Genetics Tuebingen
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.74
BayesDel_addAF
Benign
-0.011
T
BayesDel_noAF
Uncertain
-0.070
CADD
Pathogenic
26
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.54
D
Eigen
Uncertain
0.46
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.85
T
M_CAP
Uncertain
0.22
D
MetaRNN
Uncertain
0.73
D
MetaSVM
Uncertain
0.026
D
MutationAssessor
Uncertain
2.7
M
PhyloP100
7.7
PrimateAI
Uncertain
0.74
T
PROVEAN
Pathogenic
-7.8
D
REVEL
Pathogenic
0.84
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0010
D
Polyphen
0.87
P
Vest4
0.72
MutPred
0.52
Gain of catalytic residue at F310 (P = 0.0037)
MVP
0.93
MPC
0.085
ClinPred
0.99
D
GERP RS
4.4
Varity_R
0.86
gMVP
0.66
Mutation Taster
=2/98
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587777688; hg19: chr12-58190332; API